Latest Blog Posts
What Makes Opioids So Dangerous?
| July 23rd, 2019
Opioids have been spotlighted in local and national news lately due to the painkiller crisis that has affected America for now more than a decade. The Washington Post reports that drug companies shipped 76 billion oxycodone and hydrocodone pills to communities throughout America between 2006 and 2012 alone. Per capita, most of the pills went
Read MoreGeneric Drugs May Not Be as Effective or Safe as Name-Brand Medications
| July 16th, 2019
Prescription medications are often extremely expensive, especially for patients without insurance that covers them. The cost of many prescription drugs causes patients to turn to generic medications, which are legally required to be virtually identical in chemical composition and ingredients. However, many generic drugs are manufactured overseas in plants with little to no oversight or
Read MoreFDA Announces Class I Recall of Defective Surgical Stapler and Staples
| July 9th, 2019
In April 2019, we discussed the U.S. Food and Drug Administration’s (FDA) findings of serious injuries and even deaths related to malfunctioning surgical staplers and misapplied surgical staples. In May 2019, the FDA announced that Ethicon was recalling its circular staplers due to their tendency to misfire and to fail to completely form staples, both
Read MoreClass of Diabetes Drugs Linked to Potentially Fatal Genital Infection
| July 2nd, 2019
In August 2018, the U.S. Food and Drug Administration (FDA) warned the public and healthcare providers about the risk of a class of type 2 diabetes medications called sodium-glucose cotransporter-2 (SGLT2) inhibitors causing a rare and potentially life-threatening genital infection called Fournier’s gangrene. Medications in that class of drugs include: Farxiga (dapagliflozin) Xigduo XR (dapagliflozin/metformin)
Read More